Pembrolizumab for relapsed anaplastic large cell lymphoma after allogeneic haematopoietic stem cell transplantation: efficacy and safety
Crossref DOI link: https://doi.org/10.1007/s00277-016-2764-1
Published Online: 2016-07-30
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chan, Thomas S. Y.
Khong, Pek-Lan
Kwong, Yok-Lam
License valid from 2016-07-30